CHECKPOINT THERAPEUTICS
Live / Registered — Registered (as of 01 Jun 2021)
What this means for you
Registered since 01 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87800976
- Registration number
- 6373293
- Mark type
- Stylized text
- Filed
- 16 Feb 2018
- Published for opposition
- 25 Sept 2018
- Registered
- 01 Jun 2021
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, lung diseases and tumors; Pharmaceutical preparations for the prevention and treatment of cancer; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Pharmaceutical products, namely, agents in the form of powders, capsules, and coatings for tablets for use in delivery of a wide range of pharmaceuticals
Owner
- Checkpoint Therapeutics, Inc., New York, NY, US
- Checkpoint Therapeutics, Inc., New York, NY, US
- Checkpoint Therapeutics, Inc., New York, NY, US
Prosecution history
- 03 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 27 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Mar 2021 — USE AMENDMENT FILED
- 23 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 21 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2020 — SOU EXTENSION 4 GRANTED
- 19 Oct 2020 — SOU EXTENSION 4 FILED
- 19 Oct 2020 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED